Patents by Inventor Satoru Senju

Satoru Senju has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10034900
    Abstract: An object of the present invention is to provide a method of producing a myeloid blood cell possessing a proliferative capability. According to the present invention, provided is a method of producing a myeloid blood cell possessing a proliferative capability, including forcedly expressing (A) a cMYC gene, and (B) at least one gene selected from the group consisting of a BMI1 gene, an EZH2 gene, an MDM2 gene, an MDM4 gene, and an HIF1A gene in a myeloid blood cell.
    Type: Grant
    Filed: September 28, 2011
    Date of Patent: July 31, 2018
    Assignee: NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
    Inventor: Satoru Senju
  • Patent number: 8551472
    Abstract: It is an object of the present invention to provide a method for producing a cell medicine that is effective for diseases while causing a low risk to these diseases. The present invention provides a method for producing a phagocyte that expresses a foreign protein, which comprises: a step of introducing a protein expression vector into an induced pluripotent stem cell; and a step of inducing the induced pluripotent stem cell, into which the protein expression vector has been introduced, to differentiate into a phagocyte.
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: October 8, 2013
    Assignee: National University Corporation Kumamoto University
    Inventor: Satoru Senju
  • Publication number: 20130195818
    Abstract: An object of the present invention is to provide a method of producing a myeloid blood cell possessing a proliferative capability. According to the present invention, provided is a method of producing a myeloid blood cell possessing a proliferative capability, including forcedly expressing (A) a cMYC gene, and (B) at least one gene selected from the group consisting of a BMI1 gene, an EZH2 gene, an MDM2 gene, an MDM4 gene, and an HIF1A gene in a myeloid blood cell.
    Type: Application
    Filed: September 28, 2011
    Publication date: August 1, 2013
    Applicant: NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
    Inventor: Satoru Senju
  • Publication number: 20120122214
    Abstract: It is an object of the present invention to provide a method for producing a cell medicine that is effective for diseases while causing a low risk to these diseases. The present invention provides a method for producing a phagocyte that expresses a foreign protein, which comprises: a step of introducing a protein expression vector into an induced pluripotent stem cell; and a step of inducing the induced pluripotent stem cell, into which the protein expression vector has been introduced, to differentiate into a phagocyte.
    Type: Application
    Filed: April 16, 2010
    Publication date: May 17, 2012
    Applicant: NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
    Inventor: Satoru Senju